SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-083645
Filing Date
2023-11-06
Accepted
2023-11-06 07:15:05
Documents
14
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187745-8k_optimizerx.htm   iXBRL 8-K 24428
2 PRESS RELEASE, DATED NOVEMBER 6, 2023 ea187745ex99-1_optimizerx.htm EX-99.1 116393
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4361
  Complete submission text file 0001213900-23-083645.txt   335192

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20231106.xsd EX-101.SCH 3021
5 XBRL LABEL FILE oprx-20231106_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20231106_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea187745-8k_optimizerx_htm.xml XML 3303
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 231378098
SIC: 7389 Services-Business Services, NEC